Related Experiment Videos
Should single agents be standard therapy for urothelial tract tumors?
1Memorial Sloan-Kettering Cancer Center, New York.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.
European journal of cancer (Oxford, England : 1990)·2021
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Periprostatic adipose inflammation is associated with high-grade prostate cancer.
Prostate cancer and prostatic diseases·2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.
Clinical pharmacology and therapeutics·2017
A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
The Patient Who Could Not Die.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.
Pharmacological research·2026
Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.
ACS chemical biology·2026